Latest news
Viridian Therapeutics (VRDN) Stock Rises Despite Deepening Losses And Cash Burn - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:06:18 GMTVRDN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:27:18 GMTVRDN Stock Records Biggest Single Day Gains In 45 Months – And It’s Not Just Due To A Better-Than-Feared Q1 Loss - StocktwitsStocktwits · Sat, 08 Aug 2026 03:20:31 GMTVRDN Maintained by RBC Capital -- Price Target Raised to $36.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:56:08 GMTViridian Therapeutics (VRDN) Climbs 2.4% to $23.05, Testing Key Resistance at $24.2 - Equal Weight ETF - dars.gov.etdars.gov.et · Fri, 07 Aug 2026 17:33:34 GMTViridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 16:05:30 GMTState Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership - Stock TitanStock Titan · Fri, 07 Aug 2026 15:13:34 GMTWilliam Blair Maintains Viridian Therapeutics(VRDN.US) With Buy Rating - MoomooMoomoo · Fri, 07 Aug 2026 04:35:17 GMT